Rhumbline Advisers Opko Health, Inc. Transaction History

Rhumbline Advisers

  • $104 Billion
  • Q1 2025

A detailed history of Rhumbline Advisers transactions in Opko Health, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 490,279 shares of OPK stock, worth $833,474. This represents 0.0% of its overall portfolio holdings.

Number of Shares
490,279
Previous 518,823 5.5%
Holding current value
$833,474
Previous $762,000 9.32%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 08, 2025
SELL
$1.45 - $1.94 $41,388 - $55,375
-28,544 Reduced 5.5%
490,279 $833,000
Q4 2024

Jan 30, 2025
SELL
$1.4 - $1.64 $38,911 - $45,582
-27,794 Reduced 5.08%
518,823 $762,000
Q3 2024

Nov 12, 2024
SELL
$1.21 - $1.68 $67,128 - $93,203
-55,478 Reduced 9.21%
546,617 $814,000
Q2 2024

Aug 01, 2024
BUY
$1.21 - $1.42 $728,534 - $854,974
602,095 New
602,095 $752,000
Q1 2024

May 09, 2024
BUY
$0.87 - $1.57 $15,145 - $27,332
17,409 Added 2.68%
667,426 $800,000
Q4 2023

Feb 08, 2024
BUY
$1.23 - $1.63 $1,392 - $1,845
1,132 Added 0.17%
650,017 $981,000
Q3 2023

Nov 09, 2023
BUY
$1.5 - $2.17 $271 - $392
181 Added 0.03%
648,885 $1.04 Million
Q2 2023

Aug 08, 2023
SELL
$1.37 - $2.17 $19,123 - $30,291
-13,959 Reduced 2.11%
648,704 $1.41 Million
Q1 2023

May 11, 2023
BUY
$1.06 - $1.61 $20,441 - $31,047
19,284 Added 3.0%
662,663 $967,000
Q4 2022

Feb 14, 2023
SELL
$1.05 - $2.01 $5,593 - $10,707
-5,327 Reduced 0.82%
643,379 $804,000
Q3 2022

Nov 10, 2022
BUY
$1.81 - $2.81 $76,963 - $119,484
42,521 Added 7.01%
648,706 $1.23 Million
Q2 2022

Aug 11, 2022
BUY
$2.33 - $3.61 $124,412 - $192,759
53,396 Added 9.66%
606,185 $1.53 Million
Q1 2022

May 12, 2022
SELL
$2.87 - $4.93 $181,074 - $311,043
-63,092 Reduced 10.24%
552,789 $1.9 Million
Q4 2021

Feb 10, 2022
SELL
$3.52 - $5.15 $17,512 - $25,621
-4,975 Reduced 0.8%
615,881 $2.96 Million
Q3 2021

Nov 12, 2021
BUY
$3.44 - $4.24 $62,611 - $77,172
18,201 Added 3.02%
620,856 $2.27 Million
Q2 2021

Aug 05, 2021
SELL
$3.33 - $4.55 $241,994 - $330,653
-72,671 Reduced 10.76%
602,655 $2.44 Million
Q1 2021

May 06, 2021
SELL
$4.19 - $5.99 $161,629 - $231,064
-38,575 Reduced 5.4%
675,326 $2.9 Million
Q4 2020

Feb 10, 2021
BUY
$3.27 - $4.87 $271,910 - $404,955
83,153 Added 13.18%
713,901 $2.82 Million
Q3 2020

Nov 12, 2020
SELL
$2.99 - $5.96 $263,987 - $526,208
-88,290 Reduced 12.28%
630,748 $2.33 Million
Q2 2020

Aug 13, 2020
BUY
$1.15 - $3.41 $88,142 - $261,362
76,646 Added 11.93%
719,038 $2.45 Million
Q1 2020

May 06, 2020
BUY
$1.34 - $2.32 $81,603 - $141,283
60,898 Added 10.47%
642,392 $861,000
Q4 2019

Feb 05, 2020
BUY
$1.42 - $2.17 $44,015 - $67,263
30,997 Added 5.63%
581,494 $855,000
Q3 2019

Oct 23, 2019
BUY
$1.75 - $2.47 $93,724 - $132,285
53,557 Added 10.78%
550,497 $1.15 Million
Q2 2019

Aug 14, 2019
BUY
$1.79 - $2.61 $45,813 - $66,800
25,594 Added 5.43%
496,940 $1.21 Million
Q1 2019

May 01, 2019
SELL
$2.42 - $3.83 $10,899 - $17,250
-4,504 Reduced 0.95%
471,346 $1.23 Million
Q4 2018

Jan 31, 2019
BUY
$2.46 - $3.87 $339,401 - $533,936
137,968 Added 40.83%
475,850 $1.43 Million
Q3 2018

Nov 07, 2018
BUY
$3.29 - $6.29 $2,349 - $4,491
714 Added 0.21%
337,882 $1.17 Million
Q2 2018

Aug 06, 2018
BUY
$2.99 - $4.99 $57,754 - $96,386
19,316 Added 6.08%
337,168 $1.59 Million
Q1 2018

May 02, 2018
SELL
$3.11 - $5.12 $19,471 - $32,056
-6,261 Reduced 1.93%
317,852 $1.01 Million
Q4 2017

Feb 09, 2018
SELL
$4.61 - $7.04 $15,941 - $24,344
-3,458 Reduced 1.06%
324,113 $1.59 Million
Q3 2017

Nov 06, 2017
BUY
$5.88 - $7.11 $1.93 Million - $2.33 Million
327,571
327,571 $2.25 Million

Others Institutions Holding OPK

# of Institutions
260
Shares Held
199M
Call Options Held
3.58M
Put Options Held
9.18M
View Full List

About OPKO HEALTH, INC.

OPK Quotes by TradingView
  • Ticker OPK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 771,960,000
  • Market Cap $1.31B
  • Description
  • OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
More about OPK
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email